Teladoc Health (NYSE:TDOC) Price Target Lowered to $7.00 at Barclays

Teladoc Health (NYSE:TDOC) had its target price reduced by Barclays from $8.50 to $7.00 in a research report released on Thursday morning,Benzinga reports. They currently have an equal weight rating on the health services provider’s stock.

Several other research firms have also recently commented on TDOC. TD Cowen dropped their target price on shares of Teladoc Health from $8.00 to $6.00 and set a “hold” rating on the stock in a research report on Thursday, February 26th. Deutsche Bank Aktiengesellschaft raised Teladoc Health from a “hold” rating to a “buy” rating and set a $11.00 target price for the company in a report on Tuesday, March 10th. Canaccord Genuity Group dropped their price target on Teladoc Health from $12.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Bank of America raised Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 price objective on the stock in a research report on Thursday, February 26th. Finally, JPMorgan Chase & Co. reduced their price objective on Teladoc Health from $9.00 to $7.00 and set a “neutral” rating for the company in a research note on Friday, March 13th. Six analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $7.64.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $5.53 on Thursday. The firm has a 50-day moving average of $5.30 and a 200-day moving average of $6.91. The company has a market cap of $985.64 million, a P/E ratio of -4.85 and a beta of 2.13. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.77 and a quick ratio of 2.67. Teladoc Health has a one year low of $4.40 and a one year high of $9.77.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, February 25th. The health services provider reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.05. Teladoc Health had a negative net margin of 7.92% and a negative return on equity of 9.13%. The company had revenue of $642.27 million for the quarter, compared to analyst estimates of $635.33 million. During the same period last year, the firm earned ($0.28) earnings per share. The firm’s revenue was up .3% on a year-over-year basis. Teladoc Health has set its Q1 2026 guidance at -0.450–0.350 EPS and its FY 2026 guidance at -1.100–0.700 EPS. Equities research analysts forecast that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In related news, CEO Charles Divita III sold 27,731 shares of the business’s stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $5.49, for a total transaction of $152,243.19. Following the sale, the chief executive officer directly owned 364,784 shares in the company, valued at approximately $2,002,664.16. The trade was a 7.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.58% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. IFP Advisors Inc grew its holdings in Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after buying an additional 3,210 shares in the last quarter. PNC Financial Services Group Inc. lifted its holdings in shares of Teladoc Health by 177.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after buying an additional 2,810 shares in the last quarter. Aster Capital Management DIFC Ltd lifted its holdings in shares of Teladoc Health by 101.1% in the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock worth $37,000 after buying an additional 2,425 shares in the last quarter. International Assets Investment Management LLC bought a new position in shares of Teladoc Health in the fourth quarter valued at approximately $45,000. Finally, Bayforest Capital Ltd purchased a new position in Teladoc Health during the third quarter valued at approximately $58,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.